Personalization of Clotting Factor VIII Replacement Therapy Based on Population Pharmacokinetics in Adult Patients with Severe Hemophilia a Who Frequently Switch Factor VIII Concentrates

被引：0
|
作者：
Windyga, Jerzy [1 ]
Odnoczko, Edyta [2 ]
Stefanska-Windyga, Ewa [3 ]
Baran, Beata [2 ]
Sikorska, Anna [3 ]
Gorska-Kosicka, Magdalena [4 ]
Zawilski, Janusz [5 ]
Letowska, Magdalena [6 ]
机构：
[1] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Lab Hemostasis & Metab Dis, Warsaw, Poland
[2] Inst Hematol & Transfus Med, Lab Hemostasis & Metab Dis, Warsaw, Poland
[3] Inst Hematol & Transfus Med, Clin Hemostasis Disorders, Warsaw, Poland
[4] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Warsaw, Poland
[5] INTERLAB, Poznan, Poland
[6] Inst Hematol & Transfus Med, Dept Transfus Med, Warsaw, Poland
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-164998
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8451 / 8452
页数：2
相关论文
共 50 条
  • [31] Influence of the type of factor VIII concentrates on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A: further clarifications on the cohorts' follow-up
    Goudemand, J
    Rothschild, C
    Laurian, Y
    Calvez, T
    BLOOD, 2006, 107 (09) : 3810 - 3810
  • [32] FACTOR-VIII ANTIGEN IN A PATIENT AFFECTED BY SEVERE HEMOPHILIA-A WHO HAS THE INVERSION IN THE FACTOR-VIII GENE
    PIENEMAN, WC
    VANTILBURG, NH
    REITSMA, PH
    BRIET, E
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1223 - 1223
  • [33] PHARMACOKINETICS OF FACTOR-VIII IN HEMOPHILIA PATIENTS UNDERGOING MAJOR SURGERY
    LONGO, G
    MATUCCI, M
    MESSORI, A
    MORFINI, M
    ROSSIFERRINI, P
    RICERCA IN CLINICA E IN LABORATORIO, 1986, 16 (01): : 208 - 208
  • [34] Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method
    Durisová, M
    Dedík, L
    Bátorová, A
    Sakalová, A
    Hedera, J
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1998, 20 (03): : 217 - 226
  • [35] EFFECTS OF FACTOR-VIII CONCENTRATES ON THE IMMUNE-SYSTEM OF PATIENTS WITH HEMOPHILIA
    MANNUCCI, PM
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (01) : 437 - 439
  • [36] Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
    Oldenburg, Johannes
    Chambost, Herve
    Liu, Hai
    Hawes, Charles
    You, Xiaojun
    Yang, Xinqun
    Newman, Vanessa
    Robinson, Tara M.
    Hatswell, Anthony J.
    Hinds, David
    Santos, Sandra
    Ozelo, Margareth
    ADVANCES IN THERAPY, 2024, 41 (06) : 2267 - 2281
  • [37] Immunogenicity of factor VIII concentrates in patients with hemophilia: a randomized clinical trial is warranted
    Gringeri, Alessandro
    Mannucci, Pier Mannucclo
    BLOOD, 2007, 110 (08) : 3084 - 3084
  • [38] IGG SUBCLASS CHANGES IN RESPONSE TO REPLACEMENT THERAPY WITH CLOTTING FACTOR-VIII
    SHAKIB, F
    MONOGRAPHS IN ALLERGY, 1986, 19 : 262 - 265
  • [39] Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
    Repesse, Yohann
    Costa, Catherine
    Palla, Roberta
    Moshai, Elika Farrokhi
    Borel-Derlon, Annie
    D'Oiron, Roseline
    Rothschild, Chantal
    El-Beshlawy, Amal
    Elalfy, Mohsen
    Ramanan, Vijay
    Eshghi, Peyman
    Oldenburg, Johannes
    Pavlova, Anna
    Rosendaal, Frits R.
    Peyvandi, Flora
    Kaveri, Srinivas V.
    Lacroix-Desmazes, Sebastien
    HAEMATOLOGICA, 2019, 104 (08) : E369 - E372
  • [40] Factor VIII prophylaxis for adult patients with severe hemophilia A: results of a US survey of attitudes and practices
    Walsh, C. E.
    Valentino, L. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 824 - 824
12345